Neurogene Inc.

NASDAQ: NGNE · Real-Time Price · USD
20.20
-0.91 (-4.31%)
At close: Aug 14, 2025, 3:59 PM
20.20
0.00%
Pre-market: Aug 15, 2025, 08:16 AM EDT

Neurogene Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Cash & Equivalents
58.81M 70.77M 136.59M 66.63M 111.03M 150.14M 148.21M 25.23M 59.05M 35.49M 37.89M 40.34M 77.53M 128.06M 142.47M 155.8M 165.11M 179.27M
Short-Term Investments
215.71M 221.83M 175.82M 72.36M 42.87M 19.39M 48.95M 53.28M 50.95M 47.94M 58.5M 66.54M 38.93M 141.09M n/a n/a n/a n/a
Long-Term Investments
n/a n/a n/a 339K 339K 339K 508K 508K 508K 878K 878K 878K 878K 878K 878K n/a n/a n/a
Other Long-Term Assets
1.44M 1.24M 1.31M 789K 794K 743K 764K 16K 234K 27K 58K 1.03M 1.16M 1.14M 1.18M 2.17M 2.17M 1.92M
Receivables
n/a 596K 648K 672K 647K 589K 600K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Inventory
n/a n/a n/a n/a n/a n/a n/a n/a 2.02M n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Current Assets
4.47M 997K 981K 1.6M 1.53M 1.25M 1.09M -619K 1.32M 2.2M 2.75M 1.98M 2.03M 2.31M 1.52M 696K 2.38M 2.04M
Total Current Assets
278.99M 296.4M 315.92M 143.65M 159.15M 174.14M 200.35M 79.89M 62.38M 85.64M 99.13M 108.86M 118.48M 130.37M 143.99M 156.5M 167.5M 181.31M
Property-Plant & Equipment
16.89M 17.67M 18.49M 19.34M 19.54M 20.13M 20.95M 9.17M 22.67M 11.92M 15.88M 15.81M 16.5M 16.74M 17.22M 17.27M 17.36M 16.58M
Goodwill & Intangibles
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 293K
Total Long-Term Assets
18.33M 18.9M 19.81M 20.47M 20.67M 21.21M 22.23M 9.69M 23.41M 12.82M 16.81M 17.72M 18.54M 18.76M 19.27M 19.44M 19.53M 18.8M
Total Assets
297.32M 315.3M 335.73M 164.12M 179.82M 195.35M 222.57M 89.59M 85.79M 98.46M 115.95M 126.58M 137.02M 149.13M 163.26M 175.93M 187.02M 200.1M
Account Payables
2.06M 3.06M 1.34M 1.68M 1.72M 1.52M 2.6M 2.13M 1.53M n/a 625K n/a n/a n/a 526K n/a n/a n/a
Deferred Revenue
n/a n/a n/a n/a n/a n/a n/a -2.13K 3.83M n/a -6.03K n/a n/a n/a n/a n/a n/a n/a
Short-Term Debt
3.13M n/a n/a 2.91M 2.82M 2.71M 2.6M 1.55M n/a 1.74M n/a 1.38M 1.39M 1.27M 1.22M 1.22M 1.18M 1.1M
Other Current Liabilities
12.31M 2.08M 4.68M 4.86M 3.57M 3.76M -1.58M -4.53M 728K 5.42M 4.58M 8.76M 7.79M 6.13M 3.63M 7.77M 6.41M 7.31M
Total Current Liabilities
15.44M 14.09M 15.16M 15.8M 13.07M 11.82M 22.97M 5.21M 6.84M 7.16M 11.06M 10.24M 9.27M 7.6M 8.64M 9M 7.58M 8.41M
Long-Term Debt
7.83M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Long-Term Liabilities
789K 789K 769K 697K 768K 1.06M 1.21M n/a 244.37M n/a n/a n/a n/a n/a n/a n/a n/a n/a
Total Long-Term Liabilities
8.62M 9.41M 10.2M 10.91M 11.74M 12.76M 13.58M 9.14M 248M 9.95M 10.55M 10.69M 11.04M 11.44M 11.76M 12.07M 12.37M 12.73M
Total Liabilities
24.06M 23.51M 25.36M 26.71M 24.81M 24.57M 36.55M 14.35M 254.85M 17.1M 21.62M 20.93M 20.31M 19.03M 20.4M 21.07M 19.95M 21.14M
Total Debt
10.97M 13.54M 14.24M 13.12M 13.79M 14.41M 14.97M 10.69M 4.39M 11.68M 12.07M 12.07M 12.43M 12.71M 12.98M 13.29M 13.54M 13.83M
Common Stock
n/a n/a n/a n/a n/a 170.78M n/a 1K 1K n/a n/a n/a n/a n/a n/a n/a n/a n/a
Retained Earnings
-306.96M -284.94M -262.3M -242.78M -222.57M -204.07M -187.15M -471.87M -174.96M -465.26M -451.06M -437.61M -424.54M -408.85M -393.5M -378.33M -362.88M -347.76M
Comprehensive Income
n/a n/a n/a n/a n/a n/a n/a -244.37K -13K 18K -21K -92K -72K -91.88M n/a n/a n/a n/a
Shareholders Equity
273.25M 291.8M 310.38M 137.41M 155.01M 170.78M 186.02M 75.23M -169.05M 81.36M 94.33M 105.65M 116.71M 130.09M 142.86M 154.87M 167.07M 178.97M
Total Investments
n/a 221.83M 175.82M 72.36M 43.21M 19.73M 49.45M 53.79M 51.46M 48.82M 59.38M 67.42M 39.81M 878K 878K n/a n/a n/a